跳转至内容
Merck
CN

B-069

Supelco

系统适用性试验用安非他酮混合物 溶液

12-20 μg/mL (80:20 0.001N HCl:Methanol), certified reference material, ampule of 1 mL, Cerilliant®

登录查看公司和协议定价

选择尺寸


关于此项目

经验公式(希尔记法):
C7H5O2Cl
分子量:
156.57
UNSPSC代码:
41116107
NACRES:
NA.24
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

等级

certified reference material

特点

Snap-N-Spike®/Snap-N-Shoot®

组成

3-Chlorobenzoic Acid, 12 μg/mL
1-(3-Chlorophenyl)-1-Hydroxy-2-Propanone, 20 μg/mL
1-(3-Chlorophenyl)-2-Hydroxypropan-1-one, 20 μg/mL

包装

ampule of 1 mL

制造商/商品名称

Cerilliant®

浓度

12-20 μg/mL (80:20 0.001N HCl:Methanol)

包装形式

multi-component solution

运输

wet ice

储存温度

−20°C

一般描述

Bupropion belongs to the group of antidepressant drugs and is commonly used for the management of depressive disorders and in non-nicotine anti-depressant therapy for quitting smoking. It has been proposed that its mode of action in combating smoking involves changing systems related to both the dopamine and norepinephrine neurotransmitters.

应用

These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.

法律信息

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

警示用语:

Danger

危险分类

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Flam. Liq. 3 - STOT SE 1

靶器官

Eyes,Central nervous system

WGK

WGK 2

法规信息

危险化学品
此项目有

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Bupropion is a nicotinic antagonist
Slemmer JE, et al.
Journal of Pharmacology and Experimental Therapeutics, 295(1), 321-327 (2000)
A comparison of sustained-release bupropion and placebo for smoking cessation
Hurt RD, et al.
The New England Journal of Medicine, 337(17), 1195-1202 (1997)
15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL
Fava M, et al.
Primary care companion to the Journal of clinical psychiatry, 7(3), 106-106 (2005)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持